Figures & data
Table 1 Demographics and Baseline Preoperative Parameters of Both Groups
Table 2 Visual and Refractive Outcomes of Both Groups at 12 Months
Figure 1 Difference map (12 months preop) showing 12 months outcome of a patient who underwent cross linking treatment using Flavin riboflavin dye.
![Figure 1 Difference map (12 months preop) showing 12 months outcome of a patient who underwent cross linking treatment using Flavin riboflavin dye.](/cms/asset/e66bf550-fe6d-4f55-8ab5-5c5737e82a13/doph_a_12177380_f0001_c.jpg)
Figure 2 Difference map (12 months preop) showing 12 months outcome of a patient who underwent cross linking treatment using Peschke-D riboflavin dye.
![Figure 2 Difference map (12 months preop) showing 12 months outcome of a patient who underwent cross linking treatment using Peschke-D riboflavin dye.](/cms/asset/da8c578d-aa11-4ec4-80e8-8fd605a801b5/doph_a_12177380_f0002_c.jpg)
Table 3 Visual and Refractive Outcomes of Flavin Group Over 12 Months
Table 4 Visual and Refractive Outcomes of Peschke Group Over 12 Months
Table 5 Thinnest Pachymetry Changes of Both Groups at 12 Months
Figure 7 Histogram showing change in mean spherical equivalent at 1 month, 3 months, 6 months and 12 months postoperatively.
![Figure 7 Histogram showing change in mean spherical equivalent at 1 month, 3 months, 6 months and 12 months postoperatively.](/cms/asset/fb35869b-ef89-49bd-9852-a19c64f61646/doph_a_12177380_f0007_c.jpg)